\n(U.S. Pharmaceutical Industry Weekly Report)<\/strong><\/p>\n
Each week\u2019s issue includes a feature article, usually followed by an interview article on the same topic. Recent features have covered a range of issues, from healthcare reform initiatives to new oncology treatments. Interviews are held with pharmaceutical and biotech executives, government officials, medical and legal experts. For a list of recent interview articles, please click here<\/a>.<\/p>\n Each week\u2019s issue also includes coverage of the important news developments of the week divided into regulatory news, company news, biotech news, and research news.<\/p>\n Designed to enable executives based in the U.S. or Japan to easily keep abreast of important industry trends and news developments in the U.S. market, the Shuho has quickly established itself as a standard information resource in Japanese on the U.S. pharmaceutical industry.<\/p>\n Beikoku Bio Gyokai Geppo<\/strong> Beikoku Bio Gyokai Geppo is a monthly report covering developments in and related to the biotech industry. Like its sister publication, each issue boasts a feature article and an original interview. Each issue has an additional four sections, devoted respectively to i) licensing, ii) venture capital, iii) mergers and acquisitions, IPOs, and secondary offerings and iv) stock market movements. Corporate subscribers include Japan\u2019s largest pharmaceutical companies and other life sciences companies.<\/p>\n Blue Moose Research<\/strong><\/p>\n![\"sho_ho\"](\"http:\/\/dev.msapr.com\/main\/wp-content\/uploads\/2016\/01\/sho_ho.png\")
<\/a>Beikoku Seiyaku Gyokai Shuho is a weekly report covering regulatory and industry developments in the U.S. pharmaceutical market published in Japanese by MSA Partners. Corporate subscribers to the publication include all of Japan\u2019s largest pharmaceutical and other life sciences companies.<\/p>\n
\n(U.S. Bio Industry Monthly Report)<\/a><\/strong><\/p>\n